Related Experiment Video
Updated: Mar 23, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Circulating miR155 expression level is positive with blood pressure parameters: Potential markers of target-organ
Yuqing Huang1, Jiyan Chen1, Yingling Zhou1
1a Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong General Hospital, Guangdong Academy of Medical Sciences , The First Affiliated Hospital of South China University of Technology , Guangzhou , China.
Insights
MicroRNA 155 (miR155) is significantly elevated in hypertensive patients and correlates with blood pressure and left ventricular hypertrophy. This suggests miR155 may serve as a non-invasive biomarker for hypertension and target organ damage.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Biomarker Discovery
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Left ventricular hypertrophy (LVH) is a common complication of hypertension.
- Novel non-invasive biomarkers are needed for early detection and management of hypertension and its complications.
Purpose of the Study:
- To investigate the association between microRNA 155 (miR155) expression levels and blood pressure (BP) parameters.
- To evaluate the relationship of miR155 with left ventricular hypertrophy (LVH) in patients with essential hypertension.
- To explore the potential of miR155 as a non-invasive biomarker for hypertension and target organ damage (TOD).
Main Methods:
- Assessed miR155 expression using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) in 50 hypertensive patients and 30 healthy controls.
- Measured office and 24-hour ambulatory blood pressure monitoring (ABPM) parameters.
- Evaluated left ventricular mass index (LVMI) via two-dimensional echocardiography.
- Correlated miR155 levels with BP parameters and LVMI using Spearman correlation coefficient.
Main Results:
- Hypertensive patients exhibited significantly higher miR155 expression compared to healthy controls (p < 0.001).
- Elevated miR155 levels were also observed in patients with LVH compared to those without (p < 0.001).
- miR155 expression showed significant positive correlations with office BP (SBP, DBP, PP) and 24-h ABPM parameters (mean SBP, DBP, PP), as well as with LVMI (all p < 0.05).
Conclusions:
- Circulating miR155 is upregulated in essential hypertension.
- miR155 expression levels correlate positively with blood pressure and left ventricular hypertrophy.
- miR155 may serve as a potential non-invasive biomarker for hypertension and associated target organ damage.
Objectives:
The aim of this study is to evaluate the relationship of miR155 with office and ambulatory blood pressure (BP) parameters and left ventricular hypertrophy (LVH) in patients with hypertension and healthy controls.
Methods:
We assessed the expression level of the miR155 in 50 patients with essential hypertension and 30 healthy individuals. All patients underwent two-dimensional echocardiography, office BP monitoring and ambulatory blood pressure monitoring (ABPM). Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) was used to evaluate the expression of selected miR155. The miR155 correlations between BP parameters and left ventricular mass index (LVMI) were assessed using the Spearman correlation coefficient.
Results:
We observed higher expression level of miR155 (33.22 ± 2.59 vs. 27.30 ± 1.76; p < 0.001) in hypertensive patients compared with healthy control individuals, as well as in LVH to nLVH group (33.00 ± 2.78 vs. 27.28 ± 1.76; p < 0.001). MiR155 expression level showed significant positive correlations with office measurement of systolic blood pressure (SBP) (r = 0.634, p < 0.001), diastolic blood pressure (DBP) (r = 0.222, p < 0.05), pulse pressure (PP) (r = 0.564, p < 0.001), respectively. And explored miR155 expression level in relation to 24-h ABPM parameters showed significant positive correlation with 24 h mean SBP (r = 0.67, p < 0.001), 24 h mean DBP (r = 0.257, p < 0.05), 24 h mean PP (r = 0.597, p < 0.001), respectively, as well as with LVMI (r = 0.591, p < 0.001).
Conclusion:
Circulating miR155 may possibly represent potential non-invasive marker of hypertension and target organ damage (TOD) in essential hypertensive patients.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Blood Pressure
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Measurement of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:

